Thijs Hendrikx
- Rheumatology top 0.5%
- Immunology top 2%
- Hematology top 1%
- Oncology top 10%
- Dermatology top 5%
- Co-authors
- Keith S. KanikSujatha MenonDésirée van der HeijdeCunshan WangPhilip J. MeaseCarla C. BaanDafna D. GladmanElizabeth M. Kudlacz
- Topics
- Rheumatoid Arthritis Research and Therapies (38 papers)Spondyloarthritis Studies and Treatments (26 papers)Autoimmune and Inflammatory Disorders Research (21 papers)
- Cited by
- RheumatologyHematologyImmunology
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
Thijs Hendrikx
49 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Rheumatology 1.5k
- Immunology 1.2k
- Hematology 878
- Oncology 284
- Dermatology 142
Countries citing papers authored by Thijs Hendrikx
This map shows the geographic impact of Thijs Hendrikx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thijs Hendrikx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thijs Hendrikx more than expected).
Fields of papers citing papers by Thijs Hendrikx
This network shows the impact of papers produced by Thijs Hendrikx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thijs Hendrikx. The network helps show where Thijs Hendrikx may publish in the future.
Co-authorship network of co-authors of Thijs Hendrikx
This figure shows the co-authorship network connecting the top 25 collaborators of Thijs Hendrikx. A scholar is included among the top collaborators of Thijs Hendrikx based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thijs Hendrikx. Thijs Hendrikx is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 16 | |
| 3 | 34 | |
| 4 | 22 | |
| 5 | Changes in Lymphocytes and Lymphocyte Subsets in Tofacitinib-Treated Patients with Psoriatic Arthritis | 1 |
| 6 | 1 | |
| 7 | 194 | |
| 8 | 34 | |
| 9 | 3 | |
| 10 | Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging studybreakdown → | 272 |
| 11 | Safety and Efficacy of Tofacitinib, an Oral Janus Kinase Inhibitor, up to 36 Months in Patients with Active Psoriatic Arthritis: Data from the Second Interim Analysis of OPAL Balance, an Open-Label, Long-Term Extension Study | 2 |
| 12 | Tofacitinib Improves Composite Endpoint Measures of Disease in Patients with Psoriatic Arthritis | 3 |
| 13 | Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitorsbreakdown → | 378 |
| 14 | Tofacitinib in Patients with Ankylosing Spondylitis: A Phase 2, 16-Week, Randomized, Placebo-Controlled, Dose-Ranging Study | 3 |
| 15 | 59 | |
| 16 | 8 | |
| 17 | 48 | |
| 18 | 78 | |
| 19 | 83 | |
| 20 | 5 |
About Thijs Hendrikx
Thijs Hendrikx is a scholar working on Rheumatology, Transplantation and Hematology, having authored 49 papers that have together received 2.1k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (38 papers), Spondyloarthritis Studies and Treatments (26 papers) and Autoimmune and Inflammatory Disorders Research (21 papers). The work is most often cited by research in Rheumatology (1.5k citations), Hematology (878 citations) and Immunology (1.2k citations). Thijs Hendrikx has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Keith S. Kanik, Sujatha Menon, Désirée van der Heijde, Cunshan Wang, Philip J. Mease, Carla C. Baan, Dafna D. Gladman, Elizabeth M. Kudlacz, Daniela Graham and Oliver FitzGerald. Their work appears in journals such as New England Journal of Medicine, The Lancet and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.